A new study has demonstrated the potential of excitatory intermittent theta burst stimulation (iTBS) for reducing spasticity in patients with spinal cord injury.
Investigators hope that their findings will assist in the development of targeted treatments for pediatric brain cancers.
Researchers have found the first evidence that autoimmunity plays a role in Parkinson’s disease, showing that T cells recognize α-synuclein peptides.
The hypothesis that antidepressant response has a relevant genetic component was initially suggested by the observation that this phenotype clusters in families.
This review explores the limitations of the present technology and current challenges of SCS before reviewing some of the most important recent advances.